Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Mutations in the NF-κB signaling pathway: implications for human disease

Abstract

The nuclear factor-kappa B (NF-κB) signaling pathway is a multi-component pathway that regulates the expression of hundreds of genes that are involved in diverse and key cellular and organismal processes, including cell proliferation, cell survival, the cellular stress response, innate immunity and inflammation. Not surprisingly, mis-regulation of the NF-κB pathway, either by mutation or epigenetic mechanisms, is involved in many human and animal diseases, especially ones associated with chronic inflammation, immunodeficiency or cancer. This review describes human diseases in which mutations in the components of the core NF-κB signaling pathway have been implicated and discusses the molecular mechanisms by which these alterations in NF-κB signaling are likely to contribute to the disease pathology. These mutations can be germline or somatic and include gene amplification (e.g., REL), point mutations and deletions (REL, NFKB2, IKBA, CYLD, NEMO) and chromosomal translocations (BCL-3). In addition, human genetic diseases are briefly described wherein mutations affect protein modifiers or transducers of NF-κB signaling or disrupt NF-κB-binding sites in promoters/enhancers.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Ackerman H, Udalova I, Hull J, Kwiatkowski D . (2002). Mol Immunol 38: 849–859.

  • Alizadeh AA, Eisen M, Davis RE, Ma C, Lossos IS, Rosenwald A et al. (2000). Nature 403: 503–511.

  • Aradhya S, Courtois G, Rajkovic A, Lewis AL, Levy M, Israël A et al. (2001a). Am J Hum Genet 68: 765–771.

  • Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A et al. (2001b). Hum Mol Genet 10: 2171–2719.

  • Arcaroli J, Silva E, Maloney JP, He Q, Svetkauskaite D, Murphy JR et al. (2006). Am J Respir Crit Care Med 173: 1335–1341.

  • Au WY, Horsman DE, Ohno H, Klasa RJ, Gascoyne RD . (2002). Leukemia Lymphoma 43: 813–816.

  • Avet-Loiseau H, Vigier M, Moreau A, Mellerin MP, Gaillard F, Harousseau JL et al. (1997). Br J Haematol 97: 119–122.

  • Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W et al. (1997). J Clin Invest 100: 2961–2969.

  • Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K et al. (1996). Blood 87: 4340–4347.

  • Barth TF, Bentz M, Leithauser F, Stilgenbauer S, Siebert R, Schlotter M et al. (2001). Genes Chromosome Cancer 31: 316–325.

  • Barth TFE, Döhner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M et al. (1998). Blood 91: 4321–4330.

  • Barth TFE, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G et al. (2003). Blood 101: 3681–3686.

  • Bassères D, Baldwin Jr AS . (2006). Oncogene, this issue.

  • Bea S, Colomo L, Lopez-Guillermo A, Salaverria I, Puig X, Pinyol M et al. (2004). J Clin Oncol 22: 3498–3506.

  • Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V et al. (2005). Blood 106: 3183–3190.

  • Bentz M, Werner CA, Döhner H, Joos S, Barth TF, Siebert R et al. (1996). Blood 88: 1437–1444.

  • Berlin AL, Paller AS, Chan LS . (2002). J Am Acad Dermatol 47: 169–187.

  • Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R et al. (2000). Nat Genet 25: 160–165.

  • Borm ME, Bodegraven AA, Mulder CJ, Kraal G, Bouma G . (2005). Int J Immunogenet 32: 401–405.

  • Boulton SJ, Gartner A, Reboul J, Vaglio P, Dyson N, Hill DE et al. (2002). Science 295: 127–131.

  • Bours V, Dejardin E, Goujon-Letawe F, Merville M-P, Castronovo V . (1994). Biochem Pharmacol 47: 145–149.

  • Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K et al. (1993). Cell 72: 729–739.

  • Bowen S, Gill M, Lee DA, Fisher G, Geronemus RG, Espinel Vazquez NL et al. (2005). J Invest Dermatol 124: 919–920.

  • Brummelkamp TR, Nijman SM, Dirac AM, Bernards R . (2003). Nature 424: 797–801.

  • Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT . (1999). Oncogene 18: 3063–3070.

  • Canoz O, Rassidakis GZ, Admirand JH, Medeiros LJ . (2004). Mod Pathol 17: 911–917.

  • Cereb N, Yang SY . (1994). J Immunol 152: 3873–3883.

  • Chang C-C, Zhang J, Lombardi L, Neri A, Dalla-Favera R . (1995). Mol Cell Biol 15: 5180–5187.

  • Chen JY, Wang CM, Ma CC, Chow YH, Luo SF . (2005a). Genes Immun 6: 123–128.

  • Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES et al. (2006). Blood 107: 2477–2485.

  • Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ . (2005b). Cancer Res 65: 11771–117788.

  • Chen ZJ . (2005). Nat Cell Biol 7: 758–765.

  • Ciana P, Neri A, Cappellini C, Cavallo F, Pomati M, Chang C-C et al. (1997). Oncogene 14: 1805–1810.

  • Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS . (2000). Oncogene 19: 1123–1131.

  • Courtois G, Smahi A, Reichenbach J, Döffinger R, Cancrini C, Bonnet M et al. (2003). J Clin Invest 112: 1108–1115.

  • Daroszewska A, Ralston H . (2005). Clin Sci (London) 109: 257–263.

  • Davis RE, Brown KD, Siebenlist U, Staudt LM . (2001). J Exp Med 194: 1861–1874.

  • Dawson SJ, Wilman B, Hamsten A, Green F, Humphries S, Henney AM . (1993). J Biol Chem 268: 10739–10745.

  • De Bosscher K, Vanden Berghe W, Haegeman G . (2006). Oncogene (this issue).

  • Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG et al. (1999). Oncogene 18: 3316–3323.

  • Dejardin E, Bonizzi G, Bellahcène A, Castronovo V, Merville M-P, Bours V . (1995). Oncogene 11: 1835–1841.

  • Derudder E, Laferte A, Ferreira V, Mishal Z, Baud V, Tarantino N et al. (2003). Biochem Biophys Res Commun 308: 744–749.

  • Döffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A et al. (2001). Nat Genet 27: 277–285.

  • Donnelly GB, Teruya-Feldstein J, Quin J, Zelenetz AD, Houldsworth J, Chaganti RS . (2001). Blood 98: 302.

  • Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F et al. (1999). Blood 94: 3129–3134.

  • Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Döhner K et al. (2003). J Pathol 201: 413–420.

  • Epinat J-C, Kazandjian D, Harkness DD, Petros S, Dave J, White DW et al. (2000). Oncogene 19: 599–607.

  • Fan Y, Rayet B, Gélinas C . (2004). Oncogene 23: 1030–1042.

  • Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G et al. (2005). Blood 106: 1392–1399.

  • Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku C-L, Puel A et al. (2006). J Exp Med 203: 1745–1759.

  • Fujita T, Nolan GP, Liou H-C, Scott ML, Baltimore D . (1993). Genes Dev 7: 1354–1363.

  • Fukuhara N, Tagawa H, Kameoka Y, Kasugai Y, Karnan S, Kameoka J et al. (2006). Cancer Sci 97: 499–504.

  • Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G et al. (2004). Hum Mol Genet 13: 1763–1773.

  • Garcia JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Perez-Guillermo M et al. (2005). Histopathology 47: 101–110.

  • Gaspar DA, Matioli SR, Pavanello RC, Araujo BC, Andre M, Steman S et al. (2002). Genet Epidemiol 23: 364–374.

  • Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W et al. (2006). Oncogene, this issue.

  • Gilmore TD . (1999). Oncogene 18: 6925–6937.

  • Gilmore TD . (2006). Oncogene (this issue).

  • Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan M-E . (2001). Oncogene 20: 7098–7103.

  • Gilmore TD, Herscovitch M . (2006). Oncogene, this issue.

  • Gilmore TD, Kalaitzidis D, Liang M-C, Starczynowski DT . 2004. Oncogene 23: 2275–2286.

  • Goff LK, Neat MJ, Crawley CR, Jones L, Jones E, Lister TA et al. (2000). Br J Haematol 111: 618–625.

  • Hayden MS, Ghosh S . (2004). Genes Dev 18: 2195–2224.

  • Heinritz W, Grunewald S, Strenge S, Schütz A, Froster UG, Glander HJ et al. (2006). Br J Dermatol 154: 992–994.

  • Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, Nunoi H . (2006). Clin Immunol 119: 188–194.

  • Hinz M, Loser P, Mathas S, Krappmann D, Dörken B, Scheidereit C . (2001). Blood 97: 2798–2807.

  • Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N et al. (1996). Blood 87: 25–29.

  • Houldsworth J, Olshen AB, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J et al. (2004). Blood 103: 182–1868.

  • Hu G, Onder M, Gill M, Aksakal B, Oztas M, Gurer MA et al. (2003). J Invest Dermatol 121: 732–734.

  • Ishikawa H, Carrasco D, Claudio E, Ryseck RP, Bravo R . (1997). J Exp Med 186: 999–1014.

  • Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W . (2001). Nat Immunol 2: 223–228.

  • Janssen R, van Wengen A, Hoeve MA, ten Dam M, van der Burg M, van Dongen J et al. (2004). J Exp Med 200: 559–568.

  • Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI et al. (2003). Int J Cancer 103: 489–495.

  • Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S et al. (2002). Blood 99: 1381–1387.

  • Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M et al. (1996). Blood 87: 1571–1578.

  • Jungnickel B, Staratschek-Jox A, Bräuninger A, Spieker T, Wolf J, Diehl V et al. (2000). J Exp Med 191: 395–401.

  • Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM, Gilmore TD . (2002). Oncogene 21: 8759–8768.

  • Kalaitzidis D, Gilmore TD . (2002). Genes Chromosome Cancer 34: 129–135.

  • Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH et al. (2005). Cancer Lett 217: 11–16.

  • Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson K, McTigue MA et al. (2000). Nat Genet 25: 153–159.

  • Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D . (1999). Blood 93: 4277–4283.

  • Kim KE, Gu C, Thakur S, Viera E, Lin JC, Rabson AB . (2000). Oncogene 19: 1334–1345.

  • Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G . (2003). Nature 424: 801–805.

  • Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C . (1999). Oncogene 18: 943–953.

  • Levine A, Karban A, Eliakim R, Shaoul R, Reif S, Pacht A et al. (2005). Am J Gastroenterol 100: 407–413.

  • Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS . (2006). Cancer Lett (in press).

  • Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ . (1991). Oncogene 6: 1235–1241.

  • Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D et al. (2002). Nat Genet 32: 160–165.

  • Luo WJ, Takakuwa T, Ham MF, Wada N, Liu A, Fujita S et al. (2004). Lab Invest 84: 1193–1199.

  • Makris C, Godfrey VL, Krahn-Senftleben G, Takahashi T, Roberts JL, Schwarz T et al. (2000). Mol Cell 5: 969–979.

  • Mao X, Onadim Z, Price EA, Child F, Lillington DM, Russell-Jones R et al. (2003a). J Invest Dermatol 121: 618–627.

  • Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S . (2003b). Genes Chromosome Cancer 37: 176–185.

  • Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG et al. (2003). Blood 101: 3109–3117.

  • Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B et al. (2002). Blood 99: 1474–1477.

  • Martin-Subero JI, Knippschild U, Harder L, Barth TF, Riemke J, Grohmann S et al. (2003). Leukemia 17: 2214–2219.

  • Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R . (2006). Cell 125: 665–677.

  • McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK et al. (1997). Genes Chromosome Cancer 20: 64–72.

  • Medvedev AE, Lentschat A, Kuhns DB, Blanco JCG, Salkowski C, Zhang S et al. (2003). J Exp Med 198: 521–531.

  • Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez JM, Meeus P et al. (1996). Genes Chromosome Cancer 15: 38–47.

  • Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang C-C, Antonacci R et al. (1994). Blood 84: 3850–3860.

  • Mikkola ML, Thesleff I . (2003). Cytokine Growth Factor Rev 14: 211–224.

  • Mitchell TC, Hildeman D, Kedl RM, Teague TK, Schaefer BC, White J et al. (2001). Nat Immunol 2: 397–402.

  • Na SY, Choi JE, Kim HJ, Jhun BH, Lee YC, Lee JW . (1999). J Biol Chem 274: 28491–28496.

  • Nakagawa M, Sugiyama H, Ogawa H, Tone S, Morishita H, Ikeda H et al. (1995). Cancer Genet Cytogenet 79: 89–91.

  • Neat MJ, Foot N, Jenner M, Goff L, Ashcroft K, Burford D et al. (2001). Genes Chromosome Cancer 32: 236–243.

  • Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D et al. (2006). Hum Mol Genet 15: 531–542.

  • Neri A, Chang C-C, Lombardi L, Salina M, Malolo AT, Chaganti RSK et al. (1991). Cell 67: 1075–1087.

  • Neri A, Fracchiolla NS, Migliazza A, Trecca D, Lombardi L . (1996). Leukemia Lymphoma 23: 43–48.

  • Niehues T, Reichenbach J, Neubert J, Gudowius S, Puel A, Horneff G et al. (2004). J Allergy Clin Immunol 114: 1456–1462.

  • Ohno H, Nishikori M, Maesako Y, Haga H . (2005). Int J Hematol 82: 397–405.

  • Ohno H, Takimoto G, McKeithan TW . (1990). Cell 60: 991–997.

  • Ong ST, Hackbarth ML, Degenstein LC, Baunoch DA, Anastasi J, McKeithan TW . (1998). Oncogene 16: 2333–2343.

  • Orange JS, Levy O, Brodeur SR, Krzewski K, Roy RM, Niemela JE et al. (2004). J Allergy Clin Immunol 114: 650–656.

  • Orange JS, Levy O, Geha RS . (2005). Immuol Rev 203: 21–37.

  • Palanisamy N, Abou-Elella AA, Chaganti SR, Houldsworth J, Offit K, Louie DC et al. (2002). Genes Chromosome Cancer 33: 114–122.

  • Pallares J, Martinez-Guitarte JL, Dolcet X, Llobet D, Rue M, Palacios J et al. (2004). J Pathol 204: 569–577.

  • Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A et al. (2002). Nature 417: 861–866.

  • Perkins N . (2006). Oncogene (this issue).

  • Pham LV, Tamayo AT, Yoshimura L, Lin-Lee YC, Ford RJ . (2005). Blood 106: 3940–3947.

  • Picard C, Puel A, Bonnet M, Ku C-L, Bustamante J, Yang K et al. (2003). Science 299: 2076–2079.

  • Poblete-Gutiérrez P, Eggermann T, Holler D, Jugert FK, Beermann T, Grussendorf-Conen EI et al. (2002). J Invest Dermatol 119: 527–531.

  • Puel A, Reichenbach J, Bustamante J, Ku CL, Feinberg J, Döffinger R et al. (2006). Am J Hum Genet 78: 691–701.

  • Qi H, Ohh M . (2003). Cancer Res 63: 7076–7080.

  • Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC et al. (1998). Blood 92: 234–240.

  • Rassidakis GZ, Oyarzo MP, Medeiros LJ . (2003). Blood 102: 1146–1147.

  • Regamey A, Hohl D, Liu JW, Roger T, Kogerman P, Toftgård R et al. (2003). J Exp Med 198: 1959–1964.

  • Reiley W, Zhang M, Sun S-C . (2004). J Biol Chem 279: 55161–55167.

  • Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM . (2005). Nat Genet 37: 579–583.

  • Riehermann K, Sorg C . (1993). Trends Biochem Sci 18: 82–83.

  • Rodig SJ, Savage KJ, Nguyen V, Pinkus GS, Shipp MA, Aster JC et al. (2005). Am J Surg Pathol 29: 196–203.

  • Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al. (2002). N Engl J Med 346: 1937–1947.

  • Roussouw M, Nel HJ, Cooke GS, van Helden PD, Haol EG . (2003). Lancet 361: 1871–1872.

  • Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N et al. (2005). Blood 106: 1831–1838.

  • Saha A, Bairwa NK, Ranjan A, Gupta Y, Bamezai R . (2003). Eur J Immunogenet 30: 397–400.

  • Saito K, Kigawa T, Koshiba S, Sato K, Matsuo Y, Sakamoto A et al. (2004). Structure 12: 1719–1728.

  • Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES et al. (2004). Nature 429: 75–79.

  • Salhi A, Bornholdt D, Oeffner F, Malik S, Heid E, Happle R et al. (2004). Cancer Res 64: 5113–5117.

  • Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L et al. (2003). Blood 102: 3871–3879.

  • Schedel M, Carr D, Klopp N, Woitsch B, Illig T, Stachel D et al. (2004). J Allergy Clin Immunol 114: 1100–1105.

  • Scheidereit C . (2006). Oncogene (this issue).

  • Scheinfeld N, Hu G, Gill M, Austin C, Celebi JT . (2003). Clin Exp Dermatol 28: 539–541.

  • Schlette E, Rassidakis GZ, Canoz O, Medeiros LJ . (2005). Am J Clin Pathol 123: 465–471.

  • Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israël A, Rajewsky K et al. (2000). Mol Cell 5: 981–992.

  • Shaffer AL, Rosenwald A, Staudt LM . (2002). Nat Rev Immunol 2: 920–933.

  • Smahi A, Courtois G . (2006). Cell Death Differ 13: 843–851.

  • Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A et al. (2000). Nature 405: 466–472.

  • Soma LA, Gollin SM, Remstein ED, Ketterling RP, Flynn HC, Rajasenan KK et al. (2006). Hum Pathol 37: 218–230.

  • Spink CF, Gray LC, Davies FE, Morgan GJ, Bidwell JL . (2006). Cancer Lett (in press).

  • Starczynowski DT, Reynolds JG, Gilmore TD . (2003). Oncogene 22: 6928–6936.

  • Starczynowski DT, Reynolds JG, Gilmore TD . (2005). Oncogene 24: 7355–7368.

  • Starczynowski DT, Trautmann H, Pott C, Harder L, Arnold N, Africa JA et al. (2006). Oncogene (in press).

  • Strober W, Murray PJ, Kitani A, Watanabe T . (2006). Nat Rev Immunol 6: 9–20.

  • Suzuki N, Suzuki S, Yeh W-C . (2002a). Trends Immunol 23: 503–506.

  • Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ et al. (2002b). Nat Genet 32: 166–174.

  • Tagawa H, Suguro M, Tsuzuki S, Matsuo K, Karnan S, Ohshima K et al. (2006). Blood 106: 1770–1777.

  • Takahashi H, Feuerhake F, Monti S, Kutok JL, Aster JC, Shipp MA . (2006). Blood 107: 844–845.

  • Thakur S, Lin H-C, Tseng W-T, Kumar S, Bravo R, Foss F et al. (1994). Oncogene 9: 2335–2344.

  • Thomas RK, Wickenhauser C, Tawadros S, Diehl V, Kuppers R, Wolf J et al. (2004). Br J Haematol 126: 50–54.

  • Ting P-Y, Kastner DL, Hoffman HM . (2006). Nat Rev Immunol 6: 183–195.

  • Tobin E, Rohwedder A, Holland SM, Philips B, Carlson JA . (2003). Br J Dermatol 149: 627–633.

  • Trecca D, Guerrini L, Fracchiolla NS, Pomati M, Baldini L, Maiolo AT et al. (1997). Oncogene 14: 791–797.

  • Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G . (2003). Nature 424: 793–796.

  • Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B et al. (2000). Mol Cell Biol 20: 913–9119.

  • van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J et al. (2002). Hum Mol Genet 11: 1281–1289.

  • Veillette A . (2006). Nat Rev Immunol 6: 56–66.

  • Viatour P, Dejardin E, Warnier M, Lair F, Claudio E Bureau F, Marine J-C et al. (2004). Mol Cell 16: 35–45.

  • Wang Y, Cui H, Schroering A, Ding JL, Lane WS, McGill G et al. (2002). Nature Cell Biol 4: 888–893.

  • Welchman RL, Gordon C, Mayer RJ . (2005). Nat Rev Mol Cell Biol 6: 599–609.

  • Werner CA, Dohner H, Joos S, Trumper LH, Baudis M, Barth TF et al. (1997). Am J Pathol 151: 335–342.

  • Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF et al. (2003). Oncogene 22: 1425–1429.

  • Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin Jr AS . (2001). Mol Cell Biol 21: 8428–8436.

  • Wood KM, Roff M, Hay RT . (1998). Oncogene 16: 2131–2139.

  • Xiao G, Harhaj EW, Sun S-C . (2001). Mol Cell 7: 401–409.

  • Xiao Q, Shen N, Hedvat CV, Moskowitz CH, Sussman LK, Filippa DA et al. (2004). Appl Immunohistochem Mol Morphol 12: 211–215.

  • Yamato H, Ohshima K, Suzumiya J, Kikuchi M . (2001). Histopathology 39: 163–171.

  • Yano T, Sander CA, Andrade RE, Gauwerky CE, Croce CM, Longo DL et al. (1995). Blood 82: 1813–1819.

  • Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD et al. (2005). Arthritis Rheum 52: 2906–2916.

  • Zhang J, Chang C-C, Lombardi L, Dalla-Favera R . (1994). Oncogene 9: 1931–1937.

  • Zhang XJ, Liang YH, He PP, Yang S, Wang HY, Chen JJ et al. (2004). J Invest Dermatol 122: 658–664.

  • Zheng G, Hu L, Huang W, Chen K, Zhang X, Yang S et al. (2004). Hum Mutat 23: 400.

  • Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M . (2000). Am J Hum Genet 67: 1555–1562.

Download references

Acknowledgements

Research in the authors' laboratories is supported by Fondation pour la Recherche Medicale, Association pour la Recherche sur le Cancer, Ligue Nationale contre le Cancer (GC) and National Institutes of Health Grant CA47763 (TDG).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T D Gilmore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Courtois, G., Gilmore, T. Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25, 6831–6843 (2006). https://doi.org/10.1038/sj.onc.1209939

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209939

Keywords

This article is cited by

Search

Quick links